Counteracting Aging & Anti-Aging Tips Taken From

1. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006 Oct 19;355(16):1647-59.
   
2. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA. 2004 Nov 10;292(18):2243-8.
   
3. Villareal DT, Holloszy JO. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1003-E1008.
   
4. Schmidt PJ, Daly RC, Bloch M, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005 Feb;62(2):154-62.
   
5. Kawano H, Yasue H, Kitagawa A, et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab. 2003 Jul;88(7):3190-5.
   
6. Feldman HA, Johannes CB, Araujo AB, et al. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol. 2001 Jan 1;153(1):79-89.
   
7. Dr. Melton reports having received lecture fees from Amgen, Merck, Novartis, and Procter & Gamble. Dr. Nehra reports having served as a consultant to Pfizer. No other potential conflict of interest relevant to this article was reported.
   
8. von Muhlen D, Laughlin GA, Kritz-Silverstein D, et al. The Dehydroepiandrosterone And WellNess (DAWN) study: Research design and methods. Contemp Clin Trials. 2006 May 6; [Epub ahead of print]
   
9. Magri F, Cravello L, Barili L, et al. Stress and dementia: the role of the hypothalamicpituitary-adrenal axis. Aging Clin Exp Res. 2006 Apr;18(2):167-70. Review.
   
10. Martin-Du Pan R. [Prevention of cardiovascular and degenerative diseases: II. Hormones and/or Mediterranean diet] Rev Med Suisse Romande. 2003 Mar;123(3):183-9. Review.
    
11. Rommler A. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy] Gynakol Geburtshilfliche Rundsch. 2003 Apr;43(2):79-90.
    
12. Fingerova H, Matlochova J. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis] Ceska Gynekol. 1998 Apr;63(2):110-3.
    
13. Hampl R, Starka L. [Dehydroepiandrosterone, "the youth hormone", in the light of recent findings] Cas Lek Cesk. 1998 Jan 12;137(1):8-12. Review.
    
14. Feldman HA, Johannes CB, Araujo AB, et al. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol. 2001 Jan 1;153(1):79-89.
    
15. Piedrola G, Novo E, Serrano-Gotarredona J, et al. Relationship between insulin sensitivity and dehydroepiandrosterone sulfate in patients with ischemic heart disease. Horm Metab Res. 1997 Nov;29(11):566-71.
    
16. Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation. 1995 Mar 15;91(6):1757-60.
    
17. Nordmark G, Bengtsson C, Larsson A, et al. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity. 2005 Nov; 38(7): 531-40.
    
18. Meyer P, Meier CA. [Focus on dehydroepiandrosterone (DHEA)] Rev Med Suisse. 2005 Feb 9;1(6):415-8.
    
19. Cameron DR, Braunstein GD. The use of dehydroepiandrosterone therapy in clinical practice. Treat Endocrinol. 2005;4(2):95-114. Review.
    
20. Chen CC, Parker CR Jr. Adrenal androgens and the immune system. Semin Reprod Med. 2004 Nov;22(4):369-77. Review.
    
21. Chang DM, Chu SJ, Chen HC, et al. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. Ann Rheum Dis. 2004 Dec;63(12):1623-6.
    
22. Hartkamp A, Geenen R, Godaert GL, et al. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis Rheum. 2004 Nov;50(11):3591-5.
    
23. Petri MA, Mease PJ, Merrill JT, et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum. 2004 Sep;50(9):2858-68.
    
24. Hernandez-Morante JJ, Milagro F, Gabaldon JA, et al. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol. 2006 Oct;155(4):593-600.
    
25. Rabijewski M, Kozakowski J, Zgliczynski W. [The relationship between testosterone and dehydroepiandrosterone sulfate concentrations, insulin resistance and visceral obesity in elderly men] Endokrynol Pol. 2005 Nov-Dec;56(6):897-903.
    
26. Savastano S, Belfiore A, Guida B, et al. Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. J Endocrinol Invest. 2005 Jun;28(6):509-15.
27. Straub RH, Konecna L, Hrach S et al. Serum DHEA and DHEA-S are negatively correlated with serum IL-6, and DHEA inhibits secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83:2012-17.
    
28. Arlt W, Callies F, van Vlijmen JC, et al. DHEA replacement in women with adrenal insufficiency. N Engl J Med 1999; 341:1013-20.
    
29. Hayashi T et al. DHEA retards atherosclerosis formation through its conversion to estrogens: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 2000; 20: 782-92.
    
30. Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after DHEA replacement in Addison’s disease in a randomized, double-blind trial. J Clin Endocrinol Metab 2000; 85:4650-56.
    
31. Murialdo G, Nobili F, Rollero A, et al. Hippocampal perfusion and pituitary-adrenal axis in Alzheimer’s disease. Neuropsychobiology 2000; 42:51-57.
    
32. Padgett DA, Loria RM, Sheridan JF. Steroid hormone regulation of antiviral immunity. Ann N Y Acad Sci 2000; 917:935-43.
    
33. Straub RH, Scholmerich J, Zietz B. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases--substitutes of adrenal and sex hormones. Z Rheumatol. 2000;59 Suppl 2:II/108-18.

Return to Aging & Anti Aging Tips